Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Third Quarter FY2026 Financial Highlights
TECH logo

Bio-Techne Profits Surge 95% as High-Growth GMP Proteins Jump 50%

TECH8-KFiling Date: 5/6/2026
Bio-Techne Corporation
Description

What this story covers

Bio-Techne reported a 95% surge in GAAP operating income despite a 2% revenue dip. Growth was driven by a 50% increase in GMP proteins and mid-teens gains in Spatial Biology, alongside significant debt reduction and strategic divestitures.

Story snapshot

CompanyBio-Techne Corporation
TickerTECH
VariantStandard detailed
Duration12:49
Filing type8-K
PeriodQ3 2026
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-055887
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in